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.\bstract Treatment with 20 nM lcq2Sdihydroxyvitamin D, 
(1,25(OH),D,) caused a progressive increase in the activity of 
Mg’+-dependent protein serineltbreonine phosphatase type 2C 
(PPZC) in subcellular fractions of HL-60 cells, whereas PP2C 
activity was relatively constant throughout all-truns retlnoic acid- 
induced (1 PM) granulocytic differentiation. The increase in 
PPZC activity appeared to parallel the 1,25(0H),D,-induced 
phenotypic and functional changes in HL-60 cells. Immunoblot 
and Northern blot analysis indicated that the increase in PPZC 
activity corresponded to the increased expression of PPZC pro- 
tein, which was preceded by an increase in the level of mRNA for 
PPZCP. No mRNA for PP2Ccy was detected in resting or 
I ,25(0H),D,-stimulated HL-60 cells. These results suggest that 
the increased expression of PPZC is related with the 
I ,25(OH),D,-induced monocytic differentiation of HL-60 cells. 
!Cev words: HL-60 cell; Protein phosphatase; 
a,25_Dihydroxyvitamin D,; Differentiation 
/. Introduction 
Reversible phosphorylation of proteins is a key mechanism 
n signal transduction systems that control various cellular 
jrocesses, such as metabolism, progression of the cell cycle, and 
he proliferation and differentiation of cells. Human myeloid 
eukemia HL-60 cells can be induced to differentiate into mon- 
jcytes by 1,25(OH),D, or into granulocytes by all-trans retinoic 
acid [l]. Serinelthreonine protein phosphatases seem to be in- 
rolved in the differentiation of HL-60 cells, in addition to 
i)rotein kinases [2]. The major serine/threonine protein 
:)hosphatases in mammalian cells are protein phosphatase type 
(PPl), protein phosphatase type 2A (PP2A), protein phos- 
)hatase type 2B (calcineurin) and protein phosphatase type 2C 
PP2C) [3,4]. PPl and PP2A do not have an absolute require- 
,nent for divalent cations, whereas calcineurin and PP2C are 
3a2’/calmodulin- and Mg2’-dependent, respectively. The PP2C 
:nzyme is a monomeric protein of 43 kDa; it is encoded by a 
?eparate gene family that exhibits no sequence similarity to 
:enes for other phosphatases (PPl, PP2A and calcineurin) [3- 
i]. PP2C is present in many tissues at much lower levels than 
he other types of protein phosphatases. In mammalian cells, 
wo isozymes of PP2C (PP2Ca and PP2Cp) have been cloned, 
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and the two isoforms display an overall homology of 76% 
[610]. However, little is known about their physiological func- 
tions, mainly because of the unavailability of specific inhibitors 
of PP2C. It has been reported that the expression of PP2C gene 
is enhanced during MyoDl-induced myogenic differentiation 
of embryonic mesenchymal cells [ 111. We reported that okadaic 
acid and calyculin-A, potent inhibitors of PPI and PP2A, aug- 
mented the granulocytic differentiation of HL-60 cells induced 
by retinoic acid [12]. In addition, all-trans retinoic acid induces 
down-regulation of PP2A in HL-60 cells, whereas 1,25(OH),D, 
induces differential redistribution of PPl isozymes [13-161. 
Thus, while it has been shown that PPl and PP2A are involved 
in HL-60 cell differentiation, the involvement of calcineurin 
and PP2C remains to be demonstrated. 
To understand the biology of type 2C protein phosphatase, 
we investigated changes in PP2C activity and expression pat- 
terns of PP2C protein and the corresponding mRNA during the 
monocytic and the granulocytic differentiation of HL-60 cells. 
2. Materials and methods 
2.1. Reagents 
1,25(OH),D, and all-tram retinoic acid, purchased from Solvay- 
Duphar B.V. (Weesp, The Netherlands) and Sigma Chemical Co. (St. 
Louis, MO), respectively, were dissolved in ethanol (IO-’ M) and stored 
at -20°C in darkness. Okadaic acid was purchased from Wako Pure 
Chemical Ltd. (Osaka, Japan). 
2.2. Determination of cell dfferentiation 
Procedures of the maintenance of HL-60 cells and the determination 
of viable cell counts have been described elsewhere [17]. The extent of 
differentiation was assessed in terms of morphology; the ability to 
produce superoxide, as monitored by the reduction of nitroblue tetra- 
zolium (NBT, Sigma) and by analysis of the expression of CDllb 
(OKMl; Ortho Diagnostic System Inc., Raritan, NJ), CD1 lc (LeuMS; 
Becton Dickinson, Mountain View, CA) and CD14 (My4; Coulter 
Immunology, Hialeah, FL) as described previously [14,15]. Cells 
(2 x lO’/ml) were treated with or without 20 nM l,25(OH),Dj and 
harvested at appropriate times. 
2.3. Preparation of subcellular fractions 
HL-60 cells (1 x lo* cells for each sample) were treated with 20 nM 
1,25(OH),D, or with 1 PM all-tram retinoic acid, harvested at appro- 
priate times and washed three times with ice-cold Tris-HCl-buffered 
saline (pH 7.4). The cells were disrupted in 1 ml of homogenization 
buffer, which consisted of 250 mM sucrose in buffer A (20 mM Tris- 
HCI, pH 7.5, 2 mM dithiothreitol, 2 mM EDTA, 2 mM EGTA, and 
a cocktail of protease inhibitors), by a glass/glass Potter-Elvehjem ho- 
mogenizer at 4°C [12,16], and centrifuged at 1,000 x g for 10 min. The 
resulting pellet was used as the nuclear fraction, and the supematant 
was centrifuged at 100,000 x g for 1 h to separate the cytosol and 
membrane fractions. The membrane and nuclear fractions were rinsed 
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with the homogenization buffer, and resuspended with the homogeniza- 
tion buffer containing 1% NP-40. After 1 h incubation on ice, these 
fractions were sonicated and further centrifuged at 100,000 x g for 1 h 
to obtain solubilized fractions. We found NP-40 to be most suitable for 
solubilization of phosphatases since it does not inhibit phosphatase 
activities at concentrations as high as 1% (v/v). 
2.4. Measurement of PPZC activity 
[“PlPhosphorylated myosin light chains were used as the substrate 
in the assays of phosphatase activity since they are good substrates for 
PPZC [3,18]. PPZC activity was determined by monitoring the liberation 
of ‘*Pa from the substrate for 5 min at 30°C in a reaction mixture of 50 
~1 with 20 mM Tris-HCI, pH 7.4,O. 1 mg/ml BSA, 50 mM NaCl, 5 mM 
EGTA, 6 mM MgCI,, 0.5pM okadaic acid and 150pM trifluoperazine. 
Both PPI and PP2A are completely inhibited by okadaic acid at 0.5 PM 
[19]. Trifluoperazine (150 PM) was included to inhibit calcineurin com- 
pletely, but it is known that PPl, PP2A and PP2C are unaffected by 
trifluoperazine even at 150 PM [20]. Reactions were initiated by addi- 
tion of extract rather than “P-labeled substrate and terminated by the 
addition of 0.1 ml of 25% trichloroacetic acid. Then, samples were 
centrifuged after the addition of 0.1 ml BSA (5 mg/ml) and radioactivity 
in the supernatant was quantitated by scintillation counting. The extent 
of dephosphorylation was restricted to below 10%. Under these condi- 
tions, rates of dephosphorylation were linear with respect to time and 
enzyme dilution. Assays were performed in duplicate, and the radioac- 
tivity measured for blank assays without cell extract was subtracted 
from the total. The phosphatase activity was indicated as nmol of “P, 
released in 1 min per mg of protein in the extract. 
2.5. Immunoblot analysis 
Antiserum against PP2C was obtained by immunizing a rabbit with 
the full-length recombinant rat PP2Ca that had been produced in 
E. coli [21]. HL-60 cells were incubated with 20 nM 1,25(OH),D, and 
subcellular fractions, obtained as described above, were subjected to 
SDS-PAGE on a 12.5% polyacrylamide running gel. Proteins on the gel 
were transferred electrophoretically onto an Immobilon polyvinylidene 
difluoride membrane (Millipore, Bedford, MA) [13-161. The membrane 
was reacted with the PP2Cspecific antibodies, and immune complexes 
were stained by the avidin-biotin peroxidase complex method (Vecta- 
stain; Vector Laboratories, Burlingame, CA). Prestained SDS-PAGE 
standards (Bio-Rad, Richmond, CA) were used as molecular mass 
markers. Estimations of the level of PPZC in subcellular fractions were 
made densitometrically with a Molecular Dynamics scanning densito- 
meter (Sunnyvale, CA) in conjugation with the ImageQuant program 
run on a Dell personal computer (Austin, TX). The areas of individual 
peaks above background on densitometric tracings were expressed in 
arbitrary units. 
2.6. RNA isolation and northern blot analysis 
Total cellular RNA was extracted by the guanidinium isothiocyanate 
technique [22]. Northern blot procedure was performed as described 
elsewhere [13-151. The cDNA probes used were the 0.8-kb EcoRI frag- 
ment of rat PP2Ca and the 0.9-kb EcoRI-Sac1 fragment of mouse 
PPZCB [S-10]. Hybridization conditions with the 32P-labeled probe were 
as described elsewhere [13,14], and hybridized filters were exposed to 
Kodak O-mat film at -80°C or exposed to the imaging plate of an Bio 
Imaging Analyzer (BAS2000; Fuji Photo Film Co., Kanagawa, Japan). 
For quantification of relative amounts of mRNA, the intensity of im- 
ages was calculated directly by the BAS2000. 
3. Results and discussion 
The Mg*‘-dependent phosphatase activity of PP2C was as- 
sayed in cytosol, nuclear and membrane fractions of HL-60 
cells before and after treatment with 1,25(OH),D, or all-trans 
retinoic acid. The activities in cytosol, nuclear and membrane 
fractions of untreated HL-60 cells were 1.20 + 0.15,0.55 + 0.09 
and 0.25 f 0.03 nmol/mg/min (mean k S.E., n = 4), respec- 
tively: approximately 55560% of the total activity of PPZC was 
present in the cytosol fraction. Cytosol PP2C activity appeared 
to be equivalent to approximately 10% of cytosol PPI or PP2A 
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Fig. 1. Time course of changes in PPZC activity in subcellualr fractions 
of HL-60 cells stimulated with 1,25(OH),D, or all-tram retinoic acid. 
HL-60 cells (1 x lo* cells) were treated with 20 nM 1,25(OH),D3 (A) or 
1 PM all-trans retinoic acid (B), and cytosohc (o), nuclear (o), and 
membrane (A) fractions of HL-60 cells were prepared at indicated 
times. Mg”-dependent phosphatase activity was measured as described 
in section 2. Means of results from three separate experiments are 
shown; S.D. were less than 10% in all cases. 
activity in untreated HL-60 cells [1416]. As shown in Fig. 1, 
exposure of exponentially growing cells to 1,25(OH)*D, re- 
sulted in a gradual increase in the activity of cytosolic PP2C and 
the activity reached its highest level (approx. 2. l-fold increase 
over that in untreated HL-60 cells) after 4 days. Concomitantly, 
there were significant increases (2.0- and 2.2-fold) in PP2C 
activity in both the nuclear and membrane fractions (Fig. 1). 
In contrast, PP2C activity in each subcellular fraction was un- 
altered during the course of all-trans retinoic acid-induced 
granulocytic differentiation. The treatment of HL-60 cells with 
1,25(OH),D, resulted in monocytic differentiation, as shown in 
Fig. 2, and withdrawal from the cell cycle (Data not shown). 
Morphologic examination of May-Giemsa-stained prepara- 
tions showed that control, untreated HL-60 cells retained a 
blast-like phenotype throughout all the experiments, whereas 
1,25(0H),D,-treated cells gradually acquired a differentiated 
phenotype, as indicated by positivities of CD1 lb, CD1 lc and 
CD14, and the ability to reduce NBT. The increase in phos- 
phatase activity of PP2C appeared to coincide with increases 
in the positivity of the surface marker CD1 lc and the extent of 
reduction of NBT. These data suggest that an increase in PPZC 
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I ‘ig. 2. Time course of changes in positivity of surface markers and the 
~ bility to reduce NBT positivity of HL-60 cells treated with 
,25(OH)2D1. HL-60 cells were incubated with 20 nM I,25 (OH),D, 
I nd surface markers CD1 lb (o), CDllc (a) and CD14 (o), as well as 
1 he ability to reduce NBT (0) were analyzed as described in section 2. 
‘deans of the results from three separate experiments are shown; S.D. 
iere less than 10% in all cases. 
<ctivity is associated with the 1,25(0H),D,-induced monocytic 
tlifferentiation of HL-60 cells. 
To confirm the increase in PP2C phosphatase activity during 
,25(0H),D,-induced differentiation, protein expression of 
:‘P2C in subcellular fractions was investigated by Western blot 
nalysis. As shown in Fig. 3, the polyclonal antibodies against 
,‘P2C detected a major immuno-reactive protein of 43 kDa in 
.ach cellular fraction of untreated HL-60 cells. We were unable 
o estimate the concentration of PP2C accurately because puri- 
ied isozymes were not available, but we were able to compare 
:hanges in the levels of PP2C during monocytic differentiation. 
1s shown in Fig. 3, the addition of 1,25(OH),D, led to a dra- 
natic increase in the levels of PP2C protein in each subcellular 
i-action, with a peak reached at 96 h. The increases in levels 
rf PP2C protein reflected the increases in PP2C phosphatase 
activity shown in Fig. 1. 
PP2C exists as two enzymatically indistinguishable isozymes, 
i’P2Ca and PP2Cp, in mammalian cells [&lo], and the amino 
acid sequences of the two isoforms display an overall homology 
)f 76% [7,10]. However, no information is available about pos- 
;ible functional differences. To determine whether the 
I ,25(0H),D,-induced increase in levels of PP2C protein in HL- 
i0 cells would be reflected at the level of mRNA expression, 
Northern blot analysis was performed with total cellular RNA 
i-om HL-60 cells, before and after treatment with 1,25(OH)2D, 
Fig. 4). The probe for PP2CB mPNA detected a major band 
jf 2.8 kb. Treatment of HL-60 cells with 1,25(OH),D, resulted 
n a dramatic increase in the level of PP2Cp mRNA. At 12 h 
ifter treatment with 1,25(OH),D,, PP~C/J’ mRNA levels were 
j-fold higher than the basal level in untreated HL-60 cells, when 
normalized to GAPDH mRNA expression. The up-regulation 
,f PP2C,f? mRNA expression clearly preceded the 1,25(OH),D,- 
nduced monocytic differentiation. However, no PP2Ca 
mRNA was detected in resting or 1,25(0H),D,-stimulated HL- 
‘SO cells. These results are presented graphically, as the ratio of 
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intensities of PP2C mRNA-specific signals to those of GAPDH 
mRNA-specific signals at various times after the addition of 
1,25(OH)?D, to HL-60 cells (Fig. 4B). PP2Q and PP2Q’ are 
encoded by two different genes [7]. The present data suggest 
that expression of the two isotypes of PP2C might be differently 
regulated during the 1,25(OH),D,-induced monocytic differen- 
tiation of HL-60 cells. The up-regulation of PP2C may be 
r 
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Fig. 3. Time course of changes in levels of immunoreactive PPZC in 
subcellular fractions of HL-60 cells during 1,25(0H),D,-induced mon- 
ocytic differentiation. HL-60 cells (1 x 10” cells) were treated with 20 
nM 1,25(OH),D,, and each subcellular fraction was obtained as de- 
scribed in section 2. (A) Immunoblots stained with anti-PPZC antibody 
of subcellular fractions of HL-60 cells. 10 pg of cytosol protein ( A:), 
and 20 pg of nuclear ((68) and membrane (‘c ) proteins were analyzed 
with antiserum specific for PP2C as described in section 2. Molecular 
weight mass (M, x 10-j) are shown on the left. These data are from one 
representative experiment, but similar results were obtained in two 
other experiments. (B) Graphic display of levels of PP2C protein and 
as quantitated by densitometry for cytosol (o), nuclear (o), and mem- 
brane (A) fractions. Results are expressed as the extent (-fold) of the 
increase in PPZC of 43 kDa relative to the level at 0 h. 
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Fin. 4. Time course of changes in the expression of PP2C mRNA in 
HE-60 cells stimulated with-1,25(0H),Di. HL-60 cells (1 x IO8 cells) 
were treated with 20 nM 1.25(0H),D,. Total RNA (20 fig) was isolated 
from HL-60 cells at the t&es‘ind&tdd below the c&rr&onding lanes. 
(A) Northern blots of total RNA were hybridized with “P-labeled 
cDNA probes for PP2Ca and PPfC/?. The same RNA blots were 
hybridized to the GAPDH cDNA probe that detected a 1.5 kb mRNA 
soecies. for normalization of levels of RNA in each lane. (B) Graphic 
represe&tation of the relative intensities of hybridization signals due to 
PP2CB mRNA (01 normalized to the exnression of GAPDH mRNA 
obtained by densitometric scanning of the autoradiogram shown in 
panel A. The ratios of signals were determined for each time point 
following 1,25(OH),D, addition. Similar results were obtained in two 
independent experiments. 
associated with the expression of certain differentiation mark- 
ers (CD1 lc positivity and the ability to reduce NBT) related to 
monocytes, although the direct target of PP2C that is important 
for the HL-60 cell differentiation is unknown at present. The 
M. Nishikawa et al. IFEBS Letters 375 (1995) 299-303 
identification of a specific inhibitor of the PP2C enzyme would 
help us to clarify the physiological roles of PP2C in HL-60 cell 
proliferation and differentiation. 
1,25(OH),D, is capable of regulating the expression of many 
genes that are critical for development and cellular differentia- 
tion. The biologic responses are mediated by the binding to 
nuclear receptors for 1,25(OH),D, which belong to the steroid/ 
thyroid receptor superfamily. These receptors act as ligand- 
dependent transcription factors that bind to specific DNA se- 
quences [23]. Ligand-bound receptors interact with specific en- 
hancer or suppressor DNA elements to modulate gene expres- 
sion [24]. 1,25(OH)*D, modulates the expression of genes for 
a number of proteins. Our results demonstrate that the gene for 
PP2Cb is an additional gene subject to up-regulation by 
1,25(OH)*D,. Although protein kinase C is up-regulated by 
treatment with either all-trans retinoic acid or 1,25(OH),D, [2], 
the dynamics of protein phosphatases seem to differ in associ- 
ation with different pathways of differentiation. Together with 
our previous findings [12-161, the present data suggest that the 
modulation of various protein serine/threonine phosphatasts, 
in addition to the activation of protein kinases, might play an 
important role in regulating the net phosphorylation of critical 
substrate(s) that subsequently mediate the proliferation and/or 
differentiation of HL-60 cells. 
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